Cargando…

Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery

BACKGROUND: The alpha-delta bungartoxin-4 (α-δ-Bgt-4) is a potent neurotoxin produced by highly venomous snake species, Bungarus caeruleus, mainly targeting neuronal acetylcholine receptors (nAchRs) and producing adverse biological malfunctions leading to respiratory paralysis and mortality. Objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, R. Barani, Suresh, M. Xavier, Priya, B. Shanmuga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461960/
https://www.ncbi.nlm.nih.gov/pubmed/26109766
http://dx.doi.org/10.4103/0973-1296.157670
_version_ 1782375582050287616
author Kumar, R. Barani
Suresh, M. Xavier
Priya, B. Shanmuga
author_facet Kumar, R. Barani
Suresh, M. Xavier
Priya, B. Shanmuga
author_sort Kumar, R. Barani
collection PubMed
description BACKGROUND: The alpha-delta bungartoxin-4 (α-δ-Bgt-4) is a potent neurotoxin produced by highly venomous snake species, Bungarus caeruleus, mainly targeting neuronal acetylcholine receptors (nAchRs) and producing adverse biological malfunctions leading to respiratory paralysis and mortality. Objective: In this study, we predicted the three-dimensional structure of α-δ-Bgt-4 using homology modeling and investigated the conformational changes and the key residues responsible for nAchRs inhibiting activity. MATERIALS AND METHODS: From the selected plants, which are traditionally used for snake bites, the active compounds are taken and performed molecular interaction studies and also used for modern techniques like pharmacophore modeling and mapping and absorption, distribution, metabolism, elimination and toxicity analysis which may increase the possibility of success. RESULTS: Moreover, 100's of drug-like compounds were retrieved and analyzed through computational virtual screening and allowed for pharmacokinetic profiling, molecular docking and dynamics simulation. CONCLUSION: Finally the top five drug-like compounds having competing level of inhibition toward α-δ-Bgt-4 toxin were suggested based on their interaction with α-δ-Bgt-4 toxin.
format Online
Article
Text
id pubmed-4461960
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44619602015-06-24 Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery Kumar, R. Barani Suresh, M. Xavier Priya, B. Shanmuga Pharmacogn Mag Original Article BACKGROUND: The alpha-delta bungartoxin-4 (α-δ-Bgt-4) is a potent neurotoxin produced by highly venomous snake species, Bungarus caeruleus, mainly targeting neuronal acetylcholine receptors (nAchRs) and producing adverse biological malfunctions leading to respiratory paralysis and mortality. Objective: In this study, we predicted the three-dimensional structure of α-δ-Bgt-4 using homology modeling and investigated the conformational changes and the key residues responsible for nAchRs inhibiting activity. MATERIALS AND METHODS: From the selected plants, which are traditionally used for snake bites, the active compounds are taken and performed molecular interaction studies and also used for modern techniques like pharmacophore modeling and mapping and absorption, distribution, metabolism, elimination and toxicity analysis which may increase the possibility of success. RESULTS: Moreover, 100's of drug-like compounds were retrieved and analyzed through computational virtual screening and allowed for pharmacokinetic profiling, molecular docking and dynamics simulation. CONCLUSION: Finally the top five drug-like compounds having competing level of inhibition toward α-δ-Bgt-4 toxin were suggested based on their interaction with α-δ-Bgt-4 toxin. Medknow Publications & Media Pvt Ltd 2015-05 /pmc/articles/PMC4461960/ /pubmed/26109766 http://dx.doi.org/10.4103/0973-1296.157670 Text en Copyright: © Pharmacognosy Magazine http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kumar, R. Barani
Suresh, M. Xavier
Priya, B. Shanmuga
Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
title Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
title_full Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
title_fullStr Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
title_full_unstemmed Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
title_short Pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
title_sort pharmacophore modeling, in silico screening, molecular docking and molecular dynamics approaches for potential alpha-delta bungarotoxin-4 inhibitors discovery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4461960/
https://www.ncbi.nlm.nih.gov/pubmed/26109766
http://dx.doi.org/10.4103/0973-1296.157670
work_keys_str_mv AT kumarrbarani pharmacophoremodelinginsilicoscreeningmoleculardockingandmoleculardynamicsapproachesforpotentialalphadeltabungarotoxin4inhibitorsdiscovery
AT sureshmxavier pharmacophoremodelinginsilicoscreeningmoleculardockingandmoleculardynamicsapproachesforpotentialalphadeltabungarotoxin4inhibitorsdiscovery
AT priyabshanmuga pharmacophoremodelinginsilicoscreeningmoleculardockingandmoleculardynamicsapproachesforpotentialalphadeltabungarotoxin4inhibitorsdiscovery